South San Francisco, Calif. – June 22, 2010 – Genentech, Inc., a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the U.S. Food and Drug Administration (FDA) has approved Lucentis® (ranibizumab injection) for the treatment of …

FDA approves Lucentis (Ranibizumab injection) for the Treatment of macular edema following retinal vein occlusion Read more »